Human Tumour Xenografts in Anticancer Drug Development 1988
DOI: 10.1007/978-3-642-73252-2_3
|View full text |Cite
|
Sign up to set email alerts
|

Representativity of Xenografts for Clinical Cancer. Tumor and Host Characteristics as Variables of Tumor Take Rate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1988
1988
1996
1996

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…Bomholtgaard, Ry, Denmark. NMRI and triple immune-defective NIH I11 (Fodstad, 1987) nude mice were bred in our own nude mouse facility. Animals were kept in laminar air-flow rooms at constant temperature (24-26°C) and humidity (30-50%).…”
Section: Micementioning
confidence: 99%
See 1 more Smart Citation
“…Bomholtgaard, Ry, Denmark. NMRI and triple immune-defective NIH I11 (Fodstad, 1987) nude mice were bred in our own nude mouse facility. Animals were kept in laminar air-flow rooms at constant temperature (24-26°C) and humidity (30-50%).…”
Section: Micementioning
confidence: 99%
“…The availability of athymic nude mice means that the biology and chemosensitivity of human tumors can be studied in vivo (Rygaard and Povlsen, 1969;Giovanella et al, 1974Giovanella et al, , 1983Sordat et al, 1974;Shimosato et al, 1976;Ovejera et al, 1978;Fodstad et al, 1977Fodstad et al, , 1980Kyriazis et al, 1978Kyriazis et al, , 1981Bellet et al, 1979;Povlsen et al, 1982), since xenografted tumors usually have a close resemblance to the tumor of origin in morphology and in most biochemical characteristics (Sordat et al, 1974;Fodstad, 1979Fodstad, , 1987Bellet et al, 1979;Kyriazis et al, 1981;Povlsen et al, 1982;Giovanella et al, 1983;Sharkey and Fogh, 1984). A shortcoming of the model is that spontaneous metastases do not occur ordinarily in nude mice (Sharkey and Fogh, 1979;Sordat et al, 1982).…”
mentioning
confidence: 99%
“…Studies have shown that subcutaneous xenograft models can emulate clinical behavior [72±74], although recently some authors have questioned the accuracy of this data when applied to human drug trials [75]. These models have some disadvantages, however, including: (1) a low tumor take-rate for fresh clinical specimens [72,76], (2) tumor growth in an unusual tissue compartment (the subcutis), the microenvironment of which might influence study results, and (3) the lack of consistent invasion and metastasis [72,77,78], properties that are closely linked to clinical outcome in humans.…”
Section: Human Lung Tumor Xenograftsmentioning
confidence: 99%